← GMP Foundations course overview
Introduction to Pharmaceutical GMP
Lesson 1.1 · Free pharmaceutical GMP training · Optional captions and key explanations
Video and companion reading: The supplementary written sections below expand on the recorded lesson and may include later technical or regulatory clarifications. They are not necessarily narrated in the video. For the most complete learning experience, study both the video and the companion reading. Regulatory references are provided for educational use and should be checked against the current official text.
Turn captions and key explanations on or off using the controls above.
Further reading: Where GMP requirements come from
GMP requirements depend on the product, manufacturing activity and market. Important reference frameworks include US FDA 21 CFR Parts 210 and 211, European Union EudraLex Volume 4, WHO GMP guidance, PIC/S GMP guidance and India's Drugs Rules including Schedule M. This module focuses on human medicinal products; veterinary and other product categories may have different legal frameworks. These sources are not interchangeable: a manufacturer must identify the requirements applicable to its licensed operations and destination markets.
This introductory module teaches broadly shared GMP principles. It does not replace current jurisdiction-specific regulations, approved site procedures or qualified professional assessment.
Data integrity: ALCOA stands for Attributable, Legible, Contemporaneous, Original and Accurate. Additional ALCOA+ principles include Complete, Consistent, Enduring and Available. “Retained” is a practical record-control concept, not the “O” in ALCOA.
Regulatory references for further reading
21 CFR Part 211 · EU GMP Volume 4
Reference links are starting points for the applicable legal or guidance text. Check current versions and jurisdiction-specific applicability; this training is not a regulatory determination.
Readable guide to the video diagrams
Text descriptions of the main slide relationships, in presentation order. Use these with the narration transcript and companion reading. Arrows summarize relationships; they do not replace site procedures or prescribe a universal workflow. The repeated right-hand panels are reminders, not additional mandatory steps.
- The recurring manufacturing-system diagram links people and equipment to a controlled process and product quality.
- The coloured three-by-three risk matrix is illustrative. It communicates increasing relative risk; its numbers and colours are not a universal scoring standard.
- The quality-system slides connect oversight, accountability, personnel training and process controls.
- Process flow runs from input through process, monitoring and review; testing alone cannot build quality into a product.
- The vessel illustration marks equipment identification and calibration/status checks. Verify identity, cleaning and relevant instrument calibration before use.
- Documentation flow links approved instructions to execution records and review. Instructions state what to do; records show what occurred.
- Deviation and change-control illustrations reinforce recording, assessment and authorized decisions.
Read the recorded narration transcript
This transcript follows the existing recording. Read the technical clarifications and companion material as well.
00:00:00 Welcome to ValiStera Academy. In this
00:00:02 lesson, we will explore the fundamentals of
00:00:05 good manufacturing practice, commonly known as GMP.
00:00:10 Pharmaceutical manufacturing requires more than producing a
00:00:13 medicine that passes laboratory testing. It requires
00:00:17 controlled processes, trained personnel, suitable equipment, and
00:00:22 reliable documentation.
00:00:24 By the end of this lesson, you
00:00:26 will understand the purpose of GMP, its
00:00:29 core principles and how it contributes to
00:00:31 patient safety and consistent product quality.
00:00:35 Every pharmaceutical product is intended to deliver
00:00:38 a specific therapeutic benefit. However, failures in
00:00:42 manufacturing controls can create serious risks.
00:00:46 These risks may include contamination, incorrect strength,
00:00:50 product mix-ups, or inconsistent performance. Many
00:00:54 manufacturing defects cannot be identified simply by
00:00:57 testing a small sample of the finished batch.
00:01:01 That is why pharmaceutical quality must be
00:01:03 systematically managed throughout manufacturing, testing, packaging and
00:01:08 storage. GMP provides essential controls to reduce
00:01:12 these risks and protect patients.
00:01:15 GMP stands for Good Manufacturing Practice. It
00:01:20 is a system of principles and controls
00:01:22 intended to ensure that pharmaceutical products are
00:01:25 consistently manufactured and controlled according to appropriate
00:01:29 quality standards.
00:01:31 GMP covers activities such as personnel training,
00:01:35 equipment maintenance, cleaning, manufacturing operations, quality control
00:01:40 and documentation. For example, a pharmaceutical mixing
00:01:44 vessel should be suitable for its intended purpose, properly maintained and cleaned according to
00:01:50 approved procedures.
00:01:52 GMP is not a single test or
00:01:55 certificate. It is an ongoing system of
00:01:58 controlled operations and quality oversight.
00:02:01 A pharmaceutical quality system, or PQS, brings
00:02:05 together the arrangements used to manage product quality. GMP is an essential part of
00:02:11 this system.
00:02:12 Other important elements include quality risk management,
00:02:16 change management, corrective and preventive actions, management
00:02:20 responsibilities, and continual improvement. For example, if
00:02:24 a recurring equipment problem is identified, the
00:02:27 quality system should support investigation, appropriate corrective
00:02:31 action, and evaluation of whether the action was effective.
00:02:36 An effective quality system is therefore proactive
00:02:39 as well as reactive.
00:02:41 One of the most important GMP principles
00:02:44 is that finished product testing alone cannot
00:02:47 provide complete assurance of quality. Consider a
00:02:51 manufacturing process with inadequate mixing controls.
00:02:55 Even if the finished product samples meet
00:02:57 their specifications, that result alone may not
00:03:00 demonstrate that every part of the batch was manufactured consistently. GMP, therefore, emphasizes suitable
00:03:08 process design, defined operating parameters, in-process
00:03:12 controls, monitoring and documented verification.
00:03:16 Testing remains essential, but it works together
00:03:19 with manufacturing controls rather than replacing them.
00:03:23 People play a critical role in pharmaceutical quality. Personnel must have appropriate qualifications, training
00:03:30 and experience for their assigned responsibilities.
00:03:34 Training should cover relevant GMP principles, approved
00:03:38 procedures, and specific operational activities. For example,
00:03:43 an operator responsible for equipment cleaning should
00:03:46 understand the approved cleaning procedure, required precautions,
00:03:50 and associated documentation.
00:03:53 Training effectiveness and continuing competence should be
00:03:56 managed according to applicable requirements and company
00:04:00 procedures. Having a training record does not
00:04:03 automatically demonstrate that a person can perform
00:04:06 every assigned activity correctly.
00:04:09 Pharmaceutical manufacturing requires suitable premises, equipment and
00:04:14 supporting utilities. Facilities should be designed and
00:04:17 maintained to support controlled operations and reduce
00:04:21 contamination or mix-up risks.
00:04:24 Equipment should be appropriate for its intended use and subject to relevant maintenance, calibration
00:04:30 and qualification activities. Supporting utilities, such as
00:04:34 pharmaceutical water, compressed gases, and HVAC systems,
00:04:39 may also require defined controls depending on
00:04:42 their intended use and associated risks.
00:04:45 Equipment qualification helps provide documented evidence that
00:04:49 a system is suitable for its intended
00:04:52 purpose. We will explore qualification in detail
00:04:55 in later lessons.
00:04:57 Documentation is fundamental to GMP because it
00:05:01 communicates instructions and provides evidence of performed
00:05:04 activities. Standard operating procedures describe how defined
00:05:09 activities should be carried out.
00:05:12 Records demonstrate what was actually performed, observed,
00:05:15 and reviewed. GMP documentation should be accurate,
00:05:20 attributable, legible, contemporaneous, and appropriately retained.
00:05:25 For example, when an equipment qualification test
00:05:28 is executed, the results should be recorded
00:05:31 in accordance with the approved protocol and
00:05:34 applicable documentation procedures. Reliable records support traceability,
00:05:39 investigations, and quality decisions.
00:05:43 Manufacturing and quality control have complementary responsibilities.
00:05:48 Manufacturing personnel carry out production activities according
00:05:52 to approved instructions and defined process controls.
00:05:56 Quality control performs sampling, testing, and other
00:06:00 laboratory-related activities according to established procedures.
00:06:05 The pharmaceutical quality system also includes independent
00:06:08 quality oversight and defined responsibilities for reviewing
00:06:11 records, evaluating deviations and authorizing quality decisions.
00:06:17 A batch should not be released merely
00:06:19 because a laboratory result is acceptable. The
00:06:22 applicable manufacturing, documentation and release requirements must
00:06:27 also be satisfied.
00:06:29 Even well-controlled pharmaceutical operations can experience
00:06:33 unexpected events. A deviation occurs when an
00:06:37 activity or result differs from an applicable
00:06:39 approved requirement or established expectation.
00:06:44 Deviations should be documented and evaluated according
00:06:47 to their potential impact. Where appropriate, an
00:06:50 investigation identifies contributing factors and supports corrective
00:06:55 or preventive actions.
00:06:57 Change control provides a structured approach for
00:07:00 evaluating proposed changes before implementation, including their
00:07:05 potential effect on product quality and validated
00:07:08 status. These systems help organizations maintain control
00:07:12 and improve their processes.
00:07:15 Consider a pharmaceutical manufacturing vessel prepared for
00:07:18 production. Before use, personnel may need to
00:07:22 verify the equipment's identification, cleaning status, calibration
00:07:26 status of relevant instruments and readiness for
00:07:29 the intended manufacturing operation. The applicable checks
00:07:33 depend on the equipment, process and approved procedures.
00:07:37 Now imagine that a critical temperature sensor
00:07:40 is found outside its calibration validity period.
00:07:44 The appropriate response is not simply to
00:07:47 continue production.
00:07:49 The situation should be assessed through the relevant quality procedures to determine the equipment
00:07:54 suitability for use and any potential product
00:07:57 quality impact. This example demonstrates how GMP
00:08:01 principles guide everyday decisions.
00:08:05 Let us review the main points from
00:08:06 this lesson. GMP supports the consistent manufacture
00:08:10 and control of pharmaceutical products. Effective GMP
00:08:15 depends on trained personnel, suitable facilities and
00:08:18 equipment, controlled procedures, reliable documentation, and an
00:08:23 effective quality system.
00:08:25 Product quality cannot be assured by finished
00:08:27 product testing alone. Every person involved in
00:08:31 pharmaceutical operations contributes to maintaining quality and
00:08:35 protecting patients.
00:08:37 In our next lesson, we will explore
00:08:39 the pharmaceutical quality system and good documentation
00:08:42 practices in greater detail. Thank you for learning with ValiStera Academy.
Check your understanding
Which statement best describes GMP?